 BEDFORD, Mass.--BUSINESS WIRE--- OCUL OCUTX--Ocular Therapeutix, Inc. NASDAQ:OCUL, a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced multiple scientific presentations at the 2021 American Society of Cataract and Refractive Surgery ASCRS Annual Meeting being held July 23-27, 2021 in Las Vegas, NV. At ASCRS, we will be presenting data on multiple programs we are advancing in the clinic as w 